GCA
CBPO

Gideon Capital Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Gideon Capital Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,494
Closed -$230K – 462
2017
Q3 		$230K Buy
+2,494
New +$240K 0.23% 224

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Gideon Capital Advisors's CBPO Position: Q4 2017 in Review

Gideon Capital Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2017, closing a stake of 2,494 shares — an estimated $230K sold.

Gideon Capital Advisors first reported a position in CBPO in Q3 2017 and held it in 1 quarter. The position peaked at $230K in Q3 2017. 93 funds tracked by Wall St. Rank hold CBPO as of Q4 2017.

  • Gideon Capital Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2017 after selling out during the quarter.
  • Gideon Capital Advisors sold 2,494 China Biologic Products Holdings, Inc. shares in Q4 2017, an estimated $230K.
  • Gideon Capital Advisors first reported a position in China Biologic Products Holdings, Inc. in Q3 2017 and held it in 1 quarter.
  • Gideon Capital Advisors's China Biologic Products Holdings, Inc. position peaked at $230K in Q3 2017.
  • 93 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2017.

Based on Gideon Capital Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.